GENERAL ATLANTIC, L.P.
CIK
1017645
Location
New York, NY
Portfolio Value
Mid
$2,148,421,581
Diversification
Moderately concentrated
Filing Date
Global Rank
#1,146
/ 8,603
▼ 180
· as of Mar 2026
Top Industry
Software - Application
30.7%
3Y Alpha vs SPY
-8.6%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+40.6%
SPY
+76.5%
Annualised alpha
-8.8%
Max drawdown
−34.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
12 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
28.2%
+5.2 pts
Top 5
86.7%
+13.5 pts
Top 10
99.8%
+0.9 pts
HHI
1,744
Moderately concentrated+365
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 58.9% | $1,264,787,650 |
| Healthcare | 19.2% | $413,108,297 |
| Financial Services | 18.2% | $391,579,172 |
| Consumer Defensive | 3.7% | $78,946,462 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ALKT | Alkami Technology, Inc. | +3,346,015 | 15,337,495 | $240,338,546 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
4 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | −4,762,885 | 1,354,830 | $53,813,847 | |
| XP | XP Inc. | −2,133,000 | 20,566,133 | $391,579,172 | |
| RVMD | Revolution Medicines, Inc. | −2,105,137 | 707,791 | $68,832,674 | |
| NRIX | Nurix Therapeutics, Inc. | −795,294 | 4,101,865 | $63,578,907 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALHC | Alignment Healthcare, Inc. | 13,167,733 | $260,062,726 | |
| No positions match the current search. | ||||
12 positions ·
$2,148,421,581 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| DLO |
dLocal Ltd
Technology
|
Held | 46,656,695 | $605,137,334 | 28.17% | |
| CHYM |
Chime Financial, Inc.
Technology
|
Held | 21,259,683 | $398,193,862 | 18.53% | |
| XP |
XP Inc.
Financial Services
|
Reduced | 20,566,133 | $391,579,172 | 18.23% | |
| ALKT |
Alkami Technology, Inc.
Technology
|
Added | 15,337,495 | $240,338,546 | 11.19% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 8,031,252 | $226,882,869 | 10.56% | |
| EWCZ |
European Wax Center, Inc.
Consumer Defensive
|
Held | 13,110,492 | $75,778,643 | 3.53% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 707,791 | $68,832,674 | 3.20% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 4,101,865 | $63,578,907 | 2.96% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Reduced | 1,354,830 | $53,813,847 | 2.50% | |
| RSKD |
Riskified Ltd.
Technology
|
Held | 5,324,998 | $20,873,992 | 0.97% | |
| GROV |
Grove Collaborative Holdings, Inc.
Consumer Defensive
|
Held | 2,474,859 | $3,167,819 | 0.15% | |
| BULL |
Webull Corp
Technology
|
Held | 50,816 | $243,916 | 0.01% |